HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ya-Zhen Qin Selected Research

Ya-Zhen Qin Research Topics

Disease

30Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2024 - 07/2006
18Residual Neoplasm
10/2022 - 07/2008
16BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2021 - 03/2001
16Leukemia
05/2021 - 06/2001
13Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
03/2024 - 04/2003
8Neoplasms (Cancer)
12/2021 - 03/2001
7Philadelphia Chromosome
10/2022 - 02/2014
6Acute Promyelocytic Leukemia
11/2023 - 10/2003
5Melanoma (Melanoma, Malignant)
01/2020 - 08/2016
3Testicular Neoplasms (Testicular Cancer)
01/2020 - 02/2014
3Wilms Tumor (Wilm's Tumor)
11/2019 - 05/2016
3Infections
11/2018 - 12/2012
3Hematologic Neoplasms (Hematological Malignancy)
04/2017 - 07/2008
2Multiple Myeloma
12/2017 - 02/2014
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
04/2017 - 08/2016
2Pathologic Complete Response
01/2017 - 06/2001
2Disease Progression
02/2014 - 02/2012
1Bronchiolitis Obliterans Syndrome
01/2022
1Thrombocytopenia (Thrombopenia)
11/2019
1Myeloid Leukemia (Leukemia, Myelocytic)
10/2019
1Sarcoma (Soft Tissue Sarcoma)
10/2019
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
07/2019
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
11/2017
1Autoimmune Diseases (Autoimmune Disease)
11/2017
1Fever (Fevers)
11/2013
1Myeloproliferative Disorders (Myeloproliferative Disorder)
03/2010
1Essential Thrombocythemia
03/2010
1Primary Myelofibrosis (Myelosclerosis)
03/2010
1Hemorrhage
02/2007
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
07/2006
1Refractory Anemia with Excess of Blasts (RAEM)
06/2001

Drug/Important Bio-Agent (IBA)

9Imatinib Mesylate (Gleevec)FDA Link
10/2019 - 01/2011
6AntigensIBA
01/2020 - 02/2014
6Messenger RNA (mRNA)IBA
09/2013 - 06/2001
5InterferonsIBA
01/2022 - 11/2018
4Biomarkers (Surrogate Marker)IBA
03/2024 - 02/2014
4Proteins (Proteins, Gene)FDA Link
01/2024 - 07/2006
4Tyrosine Kinase InhibitorsIBA
10/2022 - 09/2013
3NucleophosminIBA
01/2020 - 02/2009
3ArsenicIBA
01/2018 - 08/2013
3nilotinibFDA Link
01/2017 - 02/2012
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2004 - 03/2001
3Monoclonal AntibodiesIBA
10/2003 - 02/2003
2DNA (Deoxyribonucleic Acid)IBA
03/2024 - 03/2010
2Aldehyde DehydrogenaseIBA
02/2021 - 09/2019
2Nuclear Pore Complex Proteins (Nucleoporins)IBA
12/2020 - 04/2016
2Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2018 - 08/2013
2Cytarabine (Cytosar-U)FDA LinkGeneric
05/2016 - 11/2013
2AclarubicinIBA
05/2016 - 11/2013
2Phosphotransferases (Kinase)IBA
07/2015 - 02/2012
2promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA
02/2007 - 10/2003
1Extracellular Matrix ProteinsIBA
03/2024
1Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
11/2023
1Cytokine Receptors (Cytokine Receptor)IBA
01/2023
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
10/2022
1Indicators and Reagents (Reagents)IBA
01/2022
1Dexamethasone (Maxidex)FDA LinkGeneric
12/2021
1Metalloproteases (Metalloproteinases)IBA
01/2020
1Cancer VaccinesIBA
01/2020
1ZincIBA
01/2020
1Calcium-Binding ProteinsIBA
01/2019
1Interferon-alpha (Interferon Alfa)IBA
11/2018
1Bortezomib (Velcade)FDA Link
12/2017
1Jagged-1 ProteinIBA
11/2017
1Inosine Triphosphate (ITP)IBA
11/2017
1Glycine (Aminoacetic Acid)FDA LinkGeneric
05/2017
1Cysteine (L-Cysteine)FDA Link
05/2017
1ruxolitinibIBA
01/2017
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
05/2016
1HomoharringtonineIBA
05/2016
1Dasatinib (BMS 354825)FDA Link
07/2015
1Core Binding Factors (Core-Binding Factor)IBA
12/2014
1Transaminases (Aminotransferases)IBA
11/2013
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2013
1RNA (Ribonucleic Acid)IBA
04/2011
1Thrombopoietin (c-mpl Ligand)IBA
03/2010
1Hemoglobins (Hemoglobin)IBA
02/2007
1PhosphotyrosineIBA
07/2006
1Complementary DNA (cDNA)IBA
07/2004
1tetraarsenic tetrasulfideIBA
10/2003
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
02/2003
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
02/2003
1CytokinesIBA
03/2001

Therapy/Procedure

27Hematopoietic Stem Cell Transplantation
10/2022 - 08/2003
12Drug Therapy (Chemotherapy)
01/2020 - 06/2001
11Therapeutics
10/2022 - 05/2013
5Immunotherapy
05/2021 - 08/2016
5Transplantation
12/2020 - 04/2012
4Aftercare (After-Treatment)
02/2021 - 02/2012
4Stem Cell Transplantation
01/2020 - 08/2003
3Induction Chemotherapy
10/2023 - 11/2013
2Bone Marrow Transplantation (Transplantation, Bone Marrow)
04/2017 - 06/2001
1Cell Transplantation
10/2022
1Consolidation Chemotherapy
05/2016
1CAG protocol
11/2013
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
06/2001